Infectious Disease (ID) Week 2022, Washington DC, USA

InflaRx Presentation:

Speaker: Bruno Mourvillier, MD, Medical Intensive Care Unit, University Hospital of Reims, Reims, France

Date: Friday, October 21, 2022

Time: 1:55 to 2:05 pm ET US

Presentation: "Randomized, Controlled Phase 3 Study of anti-C5a Vilobelimab’s Effect on Mortality in Critically Ill COVID-19 Patients: A Therapy for Viral Pneumonia"